Nov 28 (Reuters) - Klaria Pharma Holding AB (publ)
KLAR.ST :
* KLARIA PHARMA APPOINTS JESPER WIKLUND AS CHIEF EXECUTIVE
OFFICER
* JESPER WIKLUND HAS BEEN APPOINTED CHIEF EXECUTIVE OFFICER
AS OF
NOVEMBER 28, 2019
* SCOTT BOYER WILL CONTINUE HIS FULL-TIME INVOLVEMENT WITH
COMPANY
IN NEWLY CREATED ROLE OF CHIEF SCIENTIFIC OFFICER.
* IN COMING TWO YEARS COMPANY WILL LIKELY RECEIVE APPROVAL
OF ITS
FIRST MEDICINE, SUMATRIPTAN ALGINATE FILM
* IS NOW INCREASING FOCUS ON OUT-LICENSING TO PHARMACEUTICAL
COMPANIES AND ALSO ON FINANCING
Source text for Eikon: ID:nWkr8G7Hrp
Further company coverage: KLAR.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))